Senhwa Biosciences, NIH to co-develop COVID-19 drug

Drug Discovery |  News | 0 Comment | 27 Apr, 2020

Taiwan headquartered Senhwa Biosciences Inc announced that it has partnered with the US National Institutes of Health (N...Read more

Esperion & Otsuka to develop treatment for hypercholesterolemia

Drug Discovery |  News | 0 Comment | 23 Apr, 2020

US based Esperion has announced that the company has entered into a collaboration agreement with Otsuka Pharmaceutic...Read more

Insilico collaborates with BI for discovering therapeutic targets

Drug Discovery |  News | 0 Comment | 23 Apr, 2020

Hong Kong headquartered Insilico Medicine has announced that it has entered into a research collaboration with Boehringe...Read more

Combined treatment from existing drugs might combat COVID-19

Drug Discovery |  News | 0 Comment | 17 Apr, 2020

There is no specific drug which can fight against COVID-19 yet. Developing a specific drug is quite tough. It is no...Read more

Fujifilm accelerates favipiravir production for COVID-19 treatment

Drug Discovery |  News | 0 Comment | 16 Apr, 2020

Fujifilm is ramping up production of its antiviral treatment drug favipiravir, one of many approved drugs being tested...Read more

Australia’s CDD Cures Crohn’s Disease

Drug Discovery |  News | 1 Comment | 15 Apr, 2020

The Centre for Digestive Disease (CDD) headed by Professor Thomas Borody has cured Crohn’s Disease as reported on ...Read more

Pfizer Advances Battle Against COVID-19 on Multiple Fronts

Drug Discovery |  News | 0 Comment | 10 Apr, 2020

Pfizer Inc.on 9 April 2020, announced important advances in the battle against the global COVID-19 pandemic. Some o...Read more

Takeda and CSL Behring to Develop Potential COVID-19 Hyperimmune Therapy

Drug Discovery |  News | 0 Comment | 10 Apr, 2020

Takeda and CSL Behring, a provider of plasma-derived and recombinant therapies based in King of Prussia, PA, on 6 April ...Read more

I-Mab to develop TJM2 for treatment of COVID-19 related illness

Drug Discovery |  News | 0 Comment | 26 Mar, 2020

I-Mab Biopharma, a clinical stage biopharmaceutical company committed to the discovery, development and commercializatio...Read more

CytomX, Astellas to find cure for cancer

Drug Discovery |  News | 0 Comment | 25 Mar, 2020

US based CytomX Therapeutics and Japan based Astellas Pharma have entered into a strategic collaboration agreement focus...Read more

China clears Taletrectinib IND, issues clinical trial authorizations

Drug Discovery |  News | 0 Comment | 24 Mar, 2020

AnHeart Therapeutics, a clinical stage oncology company focused on underserved patients in global markets, has anno...Read more

Bayer, Curadev ink €250M deal for novel STING antagonists

Drug Discovery |  News | 0 Comment | 24 Mar, 2020

Bayer and Curadev Pvt. Ltd., a drug discovery company based in India, on 23 March 2020 announced a research collaboratio...Read more

Japan approves Novartis' SMA drug

Drug Discovery |  News | 0 Comment | 19 Mar, 2020

Novartis Pharma has announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) approved Zolgensma (o...Read more

Beijing Tide Pharma collaborates with Insilico for cancer therapy

Drug Discovery |  News | 0 Comment | 18 Mar, 2020

Beijing Tide Pharmaceutical Co., Ltd. (Tide), a subsidiary of Sino Biopharmaceutical Limited, and Insilico Med...Read more

Japan to test AIM ImmunoTech’s Ampligen for COVID-19

Drug Discovery |  News | 0 Comment | 10 Mar, 2020

AIM ImmunoTech, an immunopharmaceutical company focused on the development of immunological, viral and multiple cancer t...Read more

Atomwise, Bridge Bio sign $1B Deal

Drug Discovery |  News | 0 Comment | 12 Mar, 2020

US based Atomwise, the leader in using artificial intelligence (AI) for small molecule discovery, and South Korea based ...Read more

Takeda initiates development of Plasma-Derived Therapy for COVID-19

Drug Discovery |  News | 0 Comment | 05 Mar, 2020

Japan based Takeda Pharmaceutical Company will share with members of the United States Congress that it is initiating th...Read more

Eisai, FUJI YAKUHIN to work on hyperuricemia and gout treatment

Drug Discovery |  News | 1 Comment | 27 Feb, 2020

Japan based Eisai Co., Ltd. and FUJI YAKUHIN CO., LTD.  have concluded a license agreement concerning dotinurad (ge...Read more